The uncoupling of monocyte-platelet interactions from the induction of proinflammatory signaling in monocytes

Journal of Immunology

Volumn 191, Issue 11, 2013, Pages 5677-5683

  Stephen, Jillian ^a,b   Emerson, Barry ^a   Fox, Keith A A ^a   Dransfield, Ian ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CHEMOKINE RECEPTOR CCR5; G PROTEIN COUPLED RECEPTOR; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; PERTUSSIS TOXIN; PROTEIN KINASE B; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL ACTIVATION; CELL INTERACTION; COCULTURE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INCUBATION TIME; INFLAMMATION; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUPERNATANT; THROMBOCYTE; THROMBOCYTE ACTIVATION;

EID: 84888326067     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301250     Document Type: Article

References (52)

1. Sarma, J., C. A. Laan, S. Alam, A. Jha, K. A. Fox, and I. Dransfield. 2002. Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation 105: 2166-2171.
2. Furman, M. I., S. E. Benoit, M. R. Barnard, C. R. Valeri, M. L. Borbone, R. C. Becker, H. B. Hechtman, and A. D. Michelson. 1998. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J. Am. Coll. Cardiol. 31: 352-358.
3. Michelson, A. D., M. R. Barnard, L. A. Krueger, C. R. Valeri, and M. I. Furman. 2001. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 104: 1533-1537.
4. Harding, S. A., A. J. Sommerfield, J. Sarma, P. J. Twomey, D. E. Newby, B. M. Frier, and K. A. Fox. 2004. Increased CD40 ligand and platelet-monocyte aggregates in patients with type 1 diabetes mellitus. Atherosclerosis 176: 321-325.
5. Joseph, J. E., P. Harrison, I. J. Mackie, D. A. Isenberg, and S. J. Machin. 2001. Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br. J. Haematol. 115: 451-459.
6. Ashman, N., M. G. Macey, S. L. Fan, U. Azam, and M. M. Yaqoob. 2003. Increased platelet-monocyte aggregates and cardiovascular disease in end-stage renal failure patients. Nephrol. Dial. Transplant. 18: 2088-2096.
7. Bournazos, S., J. Rennie, S. P. Hart, K. A. Fox, and I. Dransfield. 2008. Monocyte functional responsiveness after PSGL-1-mediated platelet adhesion is dependent on platelet activation status. Arterioscler. Thromb. Vasc. Biol. 28: 1491-1498.
8. Neumann, F. J., N. Marx, M. Gawaz, K. Brand, I. Ott, C. Rokitta, C. Sticherling, C. Meinl, A. May, and A. Schömig. 1997. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation 95: 2387-2394.
9. Weyrich, A. S., M. R. Elstad, R. P. McEver, T. M. McIntyre, K. L. Moore, J. H. Morrissey, S. M. Prescott, and G. A. Zimmerman. 1996. Activated platelets signal chemokine synthesis by human monocytes. J. Clin. Invest. 97: 1525-1534.
10. Weyrich, A. S., T. M. McIntyre, R. P. McEver, S. M. Prescott, and G. A. Zimmerman. 1995. Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation. J. Clin. Invest. 95: 2297-2303.
11. Passacquale, G., P. Vamadevan, L. Pereira, C. Hamid, V. Corrigall, and A. Ferro. 2011. Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes. PLoS ONE 6: e25595.
12. Bournazos, S., J. Rennie, S. P. Hart, and I. Dransfield. 2008. Choice of anticoagulant critically affects measurement of circulating platelet-leukocyte complexes. Arterioscler. Thromb. Vasc. Biol. 28: e2-e3.
13. Schulz, C., M. L. von Brühl, V. Barocke, P. Cullen, K. Mayer, R. Okrojek, A. Steinhart, Z. Ahmad, E. Kremmer, B. Nieswandt, et al. 2011. EMMPRIN (CD147/basigin) mediates platelet-monocyte interactions in vivo and augments monocyte recruitment to the vascular wall. J. Thromb. Haemost. 9: 1007-1019.
14. Seizer, P., O. Borst, H. F. Langer, A. Bültmann, G. Münch, Y. Herouy, K. Stellos, B. Krämer, B. Bigalke, B. Büchele, et al. 2009. EMMPRIN (CD147) is a novel receptor for platelet GPVI and mediates platelet rolling via GPVI-EMMPRIN interaction. Thromb. Haemost. 101: 682-686.
15. Haselmayer, P., L. Grosse-Hovest, P. von Landenberg, H. Schild, and M. P. Radsak. 2007. TREM-1 ligand expression on platelets enhances neutrophil activation. Blood 110: 1029-1035.
16. da Costa Martins, P. A., J. M. van Gils, A. Mol, P. L. Hordijk, and J. J. Zwaginga. 2006. Platelet binding to monocytes increases the adhesive properties of monocytes by up-regulating the expression and functionality of beta1 and beta2 integrins. J. Leukoc. Biol. 79: 499-507.
17. Yago, T., M. Tsukuda, and M. Minami. 1999. P-selectin binding promotes the adhesion of monocytes to VCAM-1 under flow conditions. J. Immunol. 163: 367-373.
18. Piccardoni, P., R. Sideri, S. Manarini, A. Piccoli, N. Martelli, G. de Gaetano, C. Cerletti, and V. Evangelista. 2001. Platelet/polymorphonuclear leukocyte adhesion: a new role for SRC kinases in Mac-1 adhesive function triggered by P-selectin. Blood 98: 108-116.
19. Urzainqui, A., J. M. Serrador, F. Viedma, M. Yáñez- Mó, A. Rodríguez, A. L. Corbí, J. L. Alonso-Lebrero, A. Luque, M. Deckert, J. Vázquez, and F. Sánchez-Madrid. 2002. ITAM-based interaction of ERM proteins with Syk mediates signaling by the leukocyte adhesion receptor PSGL-1. Immunity 17: 401-412.
20. Totani, L., A. Piccoli, S. Manarini, L. Federico, R. Pecce, N. Martelli, C. Cerletti, P. Piccardoni, C. A. Lowell, S. S. Smyth, et al. 2006. Src-family kinases mediate an outside-in signal necessary for beta2 integrins to achieve full activation and sustain firm adhesion of polymorphonuclear leucocytes tethered on E-selectin. Biochem. J. 396: 89-98.
21. Wang, H. B., J. T. Wang, L. Zhang, Z. H. Geng,W. L. Xu, T. Xu, Y. Huo, X. Zhu, E. F. Plow, M. Chen, and J. G. Geng. 2007. P-selectin primes leukocyte integrin activation during inflammation. Nat. Immunol. 8: 882-892.
22. Evangelista, V., Z. Pamuklar, A. Piccoli, S. Manarini, G. Dell'elba, R. Pecce, N. Martelli, L. Federico, M. Rojas, G. Berton, et al. 2007. Src family kinases mediate neutrophil adhesion to adherent platelets. Blood 109: 2461-2469.
23. Serrador, J. M., J. L. Alonso-Lebrero, M. A. del Pozo, H. Furthmayr, R. Schwartz-Albiez, J. Calvo, F. Lozano, and F. Sánchez-Madrid. 1997. Moesin interacts with the cytoplasmic region of intercellular adhesion molecule-3 and is redistributed to the uropod of T lymphocytes during cell polarization. J. Cell Biol. 138: 1409-1423.
24. Serrador, J. M., A. Urzainqui, J. L. Alonso-Lebrero, J. R. Cabrero, M. C. Montoya, M. Vicente-Manzanares, M. Yáñez-Mó, and F. Sánchez-Madrid. 2002. A juxta-membrane amino acid sequence of P-selectin glycoprotein ligand-1 is involved in moesin binding and ezrin/radixin/moesin- directed targeting at the trailing edge of migrating lymphocytes. Eur. J. Immunol. 32: 1560-1566.
25. Ward, C., E. R. Chilvers, M. F. Lawson, J. G. Pryde, S. Fujihara, S. N. Farrow, C. Haslett, and A. G. Rossi. 1999. NF-kappaB activation is a critical regulator of human granulocyte apoptosis in vitro. J. Biol. Chem. 274: 4309-4318.
26. Warren, B. A., and O. Vales. 1972. The release of vesicles from platelets following adhesion to vessel walls in vitro. Br. J. Exp. Pathol. 53: 206-215.
27. Owens, A. P., III, and N. Mackman. 2011. Microparticles in hemostasis and thrombosis. Circ. Res. 108: 1284-1297.
28. Ruff, M. R., M. Polianova, Q. E. Yang, G. S. Leoung, F. W. Ruscetti, and C. B. Pert. 2003. Update on D-ala-peptide T-amide (DAPTA): a viral entry inhibitor that blocks CCR5 chemokine receptors. Curr. HIV Res. 1: 51-67.
29. Semple, J. W., J. E. Italiano, Jr., and J. Freedman. 2011. Platelets and the immune continuum. Nat. Rev. Immunol. 11: 264-274.
30. Baltus, T., P. von Hundelshausen, S. F. Mause, W. Buhre, R. Rossaint, and C. Weber. 2005. Differential and additive effects of platelet-derived chemokines on monocyte arrest on inflamed endothelium under flow conditions. J. Leukoc. Biol. 78: 435-441.
31. Kasper, B., E. Brandt, S. Brandau, and F. Petersen. 2007. Platelet factor 4 (CXC chemokine ligand 4) differentially regulates respiratory burst, survival, and cytokine expression of human monocytes by using distinct signaling pathways. J. Immunol. 179: 2584-2591.
32. Tzeng, D. Y., T. F. Deuel, J. S. Huang, R. M. Senior, L. A. Boxer, and R. L. Baehner. 1984. Platelet-derived growth factor promotes polymorphonuclear leukocyte activation. Blood 64: 1123-1128.
33. Pervushina, O., B. Scheuerer, N. Reiling, L. Behnke, J. M. Schröder, B. Kasper, E. Brandt, S. Bulfone-Paus, and F. Petersen. 2004. Platelet factor 4/CXCL4 induces phagocytosis and the generation of reactive oxygen metabolites in mononuclear phagocytes independently of Gi protein activation or intracellular calcium transients. J. Immunol. 173: 2060-2067.
34. Soga, F., N. Katoh, T. Inoue, and S. Kishimoto. 2007. Serotonin activates human monocytes and prevents apoptosis. J. Invest. Dermatol. 127: 1947-1955.
35. Dürk, T., D. Duerschmied, T. Müller, M. Grimm, S. Reuter, R. P. Vieira, K. Ayata, S. Cicko, S. Sorichter, D. J. Walther, et al. 2013. Production of serotonin by tryptophan hydroxylase 1 and release via platelets contribute to allergic airway inflammation. Am. J. Respir. Crit. Care Med. 187: 476-485.
36. de las Casas-Engel, M., A. Domínguez-Soto, E. Sierra-Filardi, R. Bragado, C. Nieto, A. Puig-Kroger, R. Samaniego, M. Loza, M. T. Corcuera, F. Gómez-Aguado, et al. 2013. Serotonin skews human macrophage polarization through HTR2B and HTR7. J. Immunol. 190: 2301-2310.
37. Katoh, N., F. Soga, T. Nara, R. Tamagawa-Mineoka, M. Nin, H. Kotani, K. Masuda, and S. Kishimoto. 2006. Effect of serotonin on the differentiation of human monocytes into dendritic cells. Clin. Exp. Immunol. 146: 354-361.
38. Friedl, P., A. T. den Boer, and M. Gunzer. 2005. Tuning immune responses: diversity and adaptation of the immunological synapse. Nat. Rev. Immunol. 5: 532-545.
39. Wang, K., Z. Zhou, X. Zhou, K. Tarakji, E. J. Topol, and A. M. Lincoff. 2001. Prevention of intimal hyperplasia with recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in the porcine coronary artery balloon injury model. J. Am. Coll. Cardiol. 38: 577-582.
40. Phillips, J. W., K. G. Barringhaus, J. M. Sanders, S. E. Hesselbacher, A. C. Czarnik, D. Manka, D. Vestweber, K. Ley, and I. J. Sarembock. 2003. Single injection of P-selectin or P-selectin glycoprotein ligand-1 monoclonal antibody blocks neointima formation after arterial injury in apolipoprotein E-deficient mice. Circulation 107: 2244-2249.
41. Tardif, J. C., J. F. Tanguay, S. S. Wright, V. Duchatelle, T. Petroni, J. C. Grégoire, R. Ibrahim, T. M. Heinonen, S. Robb, O. F. Bertrand, et al. 2013. Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial. J. Am. Coll. Cardiol. 61: 2048-2055.
42. Kling, D., C. Stucki, S. Kronenberg, D. Tuerck, E. Rhé aume, J. C. Tardif, J. Gaudreault, and C. Schmitt. 2013. Pharmacological control of platelet-leukocyte interactions by the human anti-P-selectin antibody inclacumab - preclinical and clinical studies. Thromb. Res. 131: 401-410.
43. Kutlar, A., K. I. Ataga, L. McMahon, J. Howard, F. Galacteros, W. Hagar, E. Vichinsky, A. T. Cheung, N. Matsui, and S. H. Embury. 2012. A potent oral P-selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell disease. Am. J. Hematol. 87: 536-539.
44. Krajewski, S., J. Kurz, T. Geisler, K. Peter, H. P. Wendel, and A. Straub. 2012. Combined blockade of ADP receptors and PI3-kinase p110β fully prevents platelet and leukocyte activation during hypothermic extracorporeal circulation. PLoS ONE 7: e38455.
45. Luo, W., H. Wang, M. K. Ohman, C. Guo, K. Shi, J. Wang, and D. T. Eitzman. 2012. P-selectin glycoprotein ligand-1 deficiency leads to cytokine resistance and protection against atherosclerosis in apolipoprotein E deficient mice. Atherosclerosis 220: 110-117.
46. Bursill, C. A., E. McNeill, L. Wang, O. C. Hibbitt, R. Wade-Martins, D. J. Paterson, D. R. Greaves, and K. M. Channon. 2009. Lentiviral gene transfer to reduce atherosclerosis progression by long-term CC-chemokine inhibition. Gene Ther. 16: 93-102.
47. Koenen, R. R., P. von Hundelshausen, I. V. Nesmelova, A. Zernecke, E. A. Liehn, A. Sarabi, B. K. Kramp, A. M. Piccinini, S. R. Paludan, M. A. Kowalska, et al. 2009. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat. Med. 15: 97-103.
48. Totani, L., and V. Evangelista. 2010. Platelet-leukocyte interactions in cardiovascular disease and beyond. Arterioscler. Thromb. Vasc. Biol. 30: 2357-2361.
49. Kornerup, K. N., G. P. Salmon, S. C. Pitchford, W. L. Liu, and C. P. Page. 2010. Circulating platelet-neutrophil complexes are important for subsequent neutrophil activation and migration. J. Appl. Physiol. 109: 758-767.
50. Hara, T., K. Shimizu, F. Ogawa, K. Yanaba, Y. Iwata, E. Muroi, M. Takenaka, K. Komura, M. Hasegawa, M. Fujimoto, and S. Sato. 2010. Platelets control leukocyte recruitment in a murine model of cutaneous arthus reaction. Am. J. Pathol. 176: 259-269.
51. Johansson, M. W., S. T. Han, K. A. Gunderson, W. W. Busse, N. N. Jarjour, and D. F. Mosher. 2012. Platelet activation, P-selectin, and eosinophil β1-integrin activation in asthma. Am. J. Respir. Crit. Care Med. 185: 498-507.
52. Clark, S. R., A. C. Ma, S. A. Tavener, B. McDonald, Z. Goodarzi, M. M. Kelly, K. D. Patel, S. Chakrabarti, E. McAvoy, G. D. Sinclair, et al. 2007. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med. 13: 463-469.